Innovative Models and Development Pathways of Internet Hospitals Amid Policy Guidance and Market Volatility

Internet hospitals are one-stop service platforms built on physical hospitals, primarily focusing on follow-up consultations and routine medical advice, and integrating online consultation, prescription issuance, payment, and medication delivery. Their scope of practice is mainly limited to follow-up care for chronic diseases and certain common conditions, with strict prohibitions against initial diagnoses. In recent years, the intensive rollout of national policies promoting “Internet + Healthcare” and their further implementation across various sub-sectors have driven rapid growth in internet hospitals. In particular, the COVID-19 pandemic in 2020 presented new opportunities and challenges for the development of internet hospitals.

In the post-pandemic era, digital healthcare is becoming the new normal for medical consultations and treatment, rapidly undergoing iterative upgrades. Against this backdrop,VCBeatCombination TherapyDolphin Internet Healthcare Industrial Park, atMorning of April 17, 2021, co-hosted byThe 5th Future Healthcare Top 100 Conference - Internet Hospital Innovation and Development Forum, to jointly explore the broader policy environment of “Internet + Healthcare,” how to establish a seamless online-offline healthcare service loop, the opportunities and challenges facing the development of internet hospitals, and how to better implement tiered diagnosis and treatment.

We will invite renowned industry figures and experts,Lu Qingjun, Director of the Office of the National Health and Family Planning Commission’s Telemedicine Management and Training Center、Chen Qiulin, Deputy Director of the Health Industry Development Research Center at the Chinese Academy of Social Sciences、Yang Jianchun, Dean of Baidu Health Internet Hospital、Hu Yazhou, Vice President of Taozi Internet Hospital、Wang Chenhao, VCBeat、Tian Min, Partner at Yuanjing Capital、Wu Fang, General Manager of Yuanxin Medical Technology、Wu Hao, CEO of Taozi Internet Hospital、Lu Tao, General Manager of Zhiben Internet HospitalWe have gathered to safeguard national health, strengthen the national public health protection network, and provide comprehensive, full-cycle health services, striving to become the managers and “gatekeepers” of national health.

>>>> About the Dolphin Internet Healthcare Industrial Park

By the end of 2020, the Dolphin Internet Healthcare Innovation Technology Industrial Park was established in Chengdu Chip Valley. Chengdu Chip Valley is actively developing internet healthcare innovation technologies and has planned an Internet Healthcare Innovation Technology Industrial Park with a total planned construction area of 200,000 square meters within the Chip Valley Research and Innovation City. Leveraging the advantages of resources, geography, and talent in Shuangliu District, Chengdu, the industrial park provides comprehensive service support—including physical hospital affiliation, system development, warehousing and logistics, and operational platforms—for pharmaceutical companies and innovative medical institutions seeking to develop internet healthcare solutions. This support helps these enterprises adopt the internet hospital model, facilitate online diagnosis and treatment, and establish new models for pharmaceutical distribution.

Meanwhile, to support the growth of enterprises within the industrial park, we are enhancing surrounding amenities and tailoring diverse lifestyle scenarios to meet the living needs of science and technology innovation professionals. Plans include the construction of 1,388 units of talent apartments and 996 units in the “Guixin Valley” project; additionally, the 250,000-square-meter mixed-use commercial and residential development at Lanrun City is scheduled for completion within the year. Five subway lines with eight stations are currently under accelerated construction, establishing a convenient and comfortable living circle.

The Internet Healthcare Innovation Technology Industrial Park will take driving the integrated development of the “three medical” sectors as its core objective, striving to build an internet healthcare innovation industry promotion platform that integrates pharmaceutical companies, talent, capital, innovation platforms, and collaboration networks.

>>>> About Taozi Internet Hospital

In 2017, Taozi Internet Hospital was established as a tech-driven healthcare enterprise integrating online and offline services. In January 2018, Taozi obtained the first internet hospital license issued by Chengdu’s health administrative authorities, becoming the first internet hospital in Chengdu. The company has signed strategic cooperation agreements with major Chinese e-commerce platforms, including Alibaba Group (Taobao, Tmall, and Ali Health), Meituan, Pinduoduo, and Ele.me, thereby becoming the designated medical service provider for prescription drug sales among leading national e-commerce players. Meanwhile, the company collaborates with over 1,000 mainstream pharmaceutical retail enterprises across China, providing medical services for both online and offline pharmacies. It has built an industry closed loop encompassing pharmaceutical manufacturers, pharmacy chains, physical hospitals, e-commerce platforms, and physician teams. For pharmaceutical companies, it delivers comprehensive on-the-ground healthcare solutions, including electronic prescriptions, chronic disease prescription renewals, and chronic disease management. Each month, the number of new merchant partners collaborating with the company exceeds 100.

April 16-18, 2021，VCBeatCombinedPeople's Government of Wujiang District, Suzhou City、Guangdong Zhong Nanshan Medical Foundation、Suzhou Wujiang Dongfang State-owned Capital Investment and Operation Co., Ltd.InSuzhou · WujiangCo-hosted byThe 5th Future Healthcare 100 Conference. The conference will focus on the healthcare industry, with attention to individual health, public hygiene, the healthcare industry chain, and supporting infrastructure systems. It will make its first attempt at building an industrial ecosystem for the conference, linking more possibilities in healthcare and achieving a comprehensive upgrade of the Top 100 Conference.

Confirmed Participating Companies at the 5th Future Healthcare 100 Conference:Microsoft, Intel, IBM, BOE, AliHealth, AstraZeneca, Takeda Pharmaceutical, Sanofi, GE, Roche, Terumo, Medtronic, New Horizon Health, Langzi Shares, Clarivate, Agilent, Livongo, Hims & Hers, BGI Genomics, JD Health, Sansure Biotech, Tigermed, Dian Diagnostics, KingMed Diagnostics, Wondfo, Winning Health Technology Group, DHC Software, Genetron Health, Imeik, BaiRen Medicaletc.

>>>> PartiallyConfirmed Guests

Zhang Zhiyuan| Academician of the Chinese Academy of Engineering

Chen Shiqing| Member of the U.S. National Academy of Engineering, Supercomputing Expert

Li Changming| Dean, School of Materials Science and Engineering, Suzhou University of Science and Technology; Academician of Academia Europaea

Timothy Johns | Digital Health Officer, British Consulate-General in Shanghai

Song Yijun| Representative of the Government of Ontario, Canada; Commercial Counselor of the Canadian Embassy in China

Sun Baoqing| Chairman of the Zhong Nanshan Medical Foundation of Guangdong Province

Nick Rodgers| Chairman of the South East Academic Medical System for Technology, Chairman of Destiny Pharma

Wang Tianmiao| Professor at Beihang University

Wang Jingjing| Executive Director, Tsinghua University Global Health Industry Innovation Center

Jane Jin | Head of Oxford University's Technology Transfer Office, China Region

Zhi Zhang | Business Development Manager, Technology Department, UK Medical Research Council |

Chen Fangxia| Director of Business Development, Asia Technology Transfer Center, Western University, Canada

Kimon Angelides | Founder, Livongo & Vivante

Luo Zhangwei| Chief Scientist, Suzhou Smart Healthcare Innovation Center; Former Chief AI Scientist, Siemens China Research Institute, Suzhou Branch

Liu Enmei| Deputy Director, Children's Hospital of Chongqing Medical University (Liangjiang Campus)

Chen Hongxiang| Executive Vice President, Union Shenzhen Hospital of Huazhong University of Science and Technology (Nanshan Hospital)

Tao Liang| President of Wuhan Asia Heart Hospital

Zhang Nuofu| Vice President of the First Affiliated Hospital of Guangzhou Medical University

Weng Jianping| Deputy Director of the Division of Life Sciences and Medicine, University of Science and Technology of China; President of Bengbu Medical College

Lei Juan| Deputy Director of the Western Transfer Center, West China Hospital, Sichuan University

Wei Xuejie| Vice President of Xuzhou Mining Group General Hospital

Ye Xin| Deputy Dean of Yilianzhong Beijing Research Institute

Wu Xia| Managing Director, CICC Capital

Zhang Man| Vice President, China Renaissance

Wang Xiaohui| Managing Partner, Shengjing Jiacheng Fund of Funds

Hu Chuanwei| Vice President, Hengqin Jintou Group

Li Yuhui| Founding Managing Partner, Panlin Capital

Yu Zhengkun| Founding Partner, Jifeng Capital

Zhou Yi| Partner, Shenzhen Capital Group Health Industry Fund

Tian Min| Partner at Yuanjing Capital

Tang Haofu| Chairman of Chuangrui Investment

Ren Bobing| Executive Director of Sinovation Ventures

Andrew Craig| WG Fund Partner

……

>>>> Conference Highlights

Top-Tier Guest Lineup—Led by Academicians and Scientists200+Leading Experts Present Three Days of Cutting-Edge Medical Technology, Industry Trends, and Business Innovation

Business Wisdom of Industry Leaders——40Strategic Launch by Leading Listed Companies: Insights into the Industry’s Future and Innovation Landscape

Global Perspective and Overseas Resources — FromUnited Kingdom, Israel, United States, Canada, Belgium, Germany, Denmark...and the industrial development trends and capital markets of multiple countries, linking high-quality overseas technological innovation projects

In-Depth Insights into Niche Sectors—Major Release7 copiesIndustry Research Series: Exploring Development Opportunities and Innovative Cases in Niche Sectors

Gathering the Core Forces of Future Healthcare — Release6 MajorTop 100 Lists and Awards, Converged1000+Unicorns and High-Potential Innovative Enterprises Jointly Explore Pathways for Innovative Development

Emphasizing the Translation of Scientific Research into Practical Applications——Invitation10+Hospital Presidents, Research Experts, and University Scholars: Breaking Boundaries to Explore the Integration of Industry and Research

A Forward-Looking Capital Perspective——100+Featuring forward-looking investors from GP, LP, CVC, VC, PE, FA and other financial institutions to gauge the direction of capital heat in the industry

Harnessing the Momentum of the Industrial Ecosystem——10+Ecosystem Conference of Investment Institutions and Industry Giants: Promoting Industrial Ecosystem Integration and Fission

 http://vb100.vcbeat.top/

Click the link or scan the QR code to view conference details and purchase tickets.

In recent years, Wujiang has seized new opportunities presented by the latest round of industrial transformation, vigorously fostering the development of the life and health industry. The industry has begun to take shape, giving rise to a large number of backbone enterprises such as Zhonghe Biotechnology, Shengda Pharmaceutical, Haian Pharmaceutical, Jiecheng Medical, Langkai Medical, Junmeng Biotechnology, Chukai Pharmaceutical, Weikang Biotechnology, and Nearshore Protein. A number of scientific and technological achievements have entered clinical trial and industrialization stages. Looking ahead, Wujiang District will focus on pharmaceutical biotechnology, novel medical devices, and comprehensive health services, actively building an integrated full-industry-chain system encompassing “innovative R&D—pilot-scale acceleration—industrialization.”